FDA Aims for Quick Review of Omicron Vaccines and Drugs

Posted on AllSides December 3rd, 2021
From The Center
FDA, Omicron variant, coronavirus
PHOTO: JIM WATSON/AGENCE FRANCE-PRESSE/GETTY IMAGES

The Food and Drug Administration is laying the groundwork for the rapid review of Omicron-targeted vaccines and drugs if they turn out to be needed, according to people familiar with the matter.

The agency, building on rules established earlier this year to assess shots and treatments, has been meeting with drugmakers and setting guidelines for the studies and data needed to swiftly evaluate products targeting the new Omicron Covid-19 variant, the people said.

The FDA wants to be sure Omicron shots and therapies work safely and can be made correctly before authorizing...

Read full story
Some content from this outlet may be limited or behind a paywall.

Wall Street Journal (News)

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
106765/84361
See full bias rating for Wall Street Journal (News)
Learn about media bias
https://www.wsj.com/articles/fda-aims-for-quick-review-of-omicron-vaccines-and-drugs-11638532801

More News about Public Health from the Left, Center and Right

From the Left

From the Center

From the Right